Clinical Safety

A routine dinner featuring raw oysters or a medium-rare burger might seem like a standard indulgence for most, yet for a growing segment of the global population, these meals represent a dangerous biological gamble. While a healthy individual might experience a brief bout of gastrointestinal

The precision required to dismantle a tumor without devastating the surrounding healthy tissue remains one of the most elusive targets in modern oncology. While the pharmaceutical industry has long sought to perfect antibody-drug conjugates (ADCs), the technical reality often falls short of the

The traditional landscape of oncological drug development is currently undergoing a massive transformation as Oregon Health & Science University launches an ambitious $9.2 million initiative to redefine the accuracy of preclinical testing. By establishing the Knight Cancer Precision Biofabrication

The traditional paradigm of managing localized prostate cancer has long forced men into a difficult compromise between the clinical necessity of eradicating a tumor and the deeply personal desire to maintain their physical autonomy and quality of life. For decades, the standard path involved either

The landscape of clinical governance within community pharmacies has undergone a significant transformation with the full implementation of the Learn from Patient Safety Events service. Since the transition from the older National Reporting and Learning Service was finalized, the expectation for

While chimeric antigen receptor T-cell therapy has already revolutionized the treatment of hematologic malignancies, the biological fortress surrounding solid tumors continues to pose a formidable challenge for researchers and clinicians alike. Unlike the relatively accessible nature of blood